Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
5.42
+0.14 (2.65%)
At close: Nov 26, 2025, 4:00 PM EST
5.49
+0.07 (1.29%)
After-hours: Nov 26, 2025, 5:14 PM EST
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $687.86 million as of November 26, 2025. Its market cap has increased by 48.24% in one year.
Market Cap
687.86M
Enterprise Value
664.93M
1-Year Change
48.24%
Ranking
Category
Stock Price
$5.42
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $687.86M, a decrease of -44.36%. That is a compound annual growth rate of -8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 687.86M | 70.97% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | 961.60M | 92.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 986.94B |
| Johnson & Johnson | 498.05B |
| AbbVie | 409.52B |
| UnitedHealth Group | 298.80B |
| AstraZeneca | 288.24B |
| Merck & Co. | 259.62B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 223.35B |